Global Methotrexate API Market Research Report 2024

Publication ID:

PB506243215

Publication Date:

June 17, 2024

Pages:

100

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Specialty Chemicals [2]

Manufacturing (Chemicals) [3]

Chemicals [4]

Description:

The global Methotrexate API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Methotrexate API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Methotrexate API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Methotrexate API include Rochem International, Fermion, Avra Laboratories, LGM Pharma, CF Pharma, HRV Global, Elixir Pharmaceuticals, Sigmak Lifesciences, Aspen Biopharma, Mesochem Technology, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Methotrexate API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Methotrexate API.
The Methotrexate API market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Methotrexate API market comprehensively. Regional market sizes, concerning products by Purity, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Methotrexate API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Purity, by Application, and by regions.
Market Segmentation
By Company
Rochem International
Fermion
Avra Laboratories
LGM Pharma
CF Pharma
HRV Global
Elixir Pharmaceuticals
Sigmak Lifesciences
Aspen Biopharma
Mesochem Technology
BioVectra
Bulat Pharmaceutical
South Pharmaceutical
Think Chemical
by Purity
Below 98%
Above 98%
by Application
Acute Lymphoblastic Leukemia
Non-Hodgkin's Lymphoma
Psoriasis
Rheumatoid Arthritis
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Purity, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Methotrexate API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Methotrexate API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Methotrexate API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Purity, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Methotrexate API Market Overview
1.1 Product Definition
1.2 Methotrexate API by Purity
1.2.1 Global Methotrexate API Market Value Growth Rate Analysis by Purity: 2023 VS 2030
1.2.2 Below 98%
1.2.3 Above 98%
1.3 Methotrexate API by Application
1.3.1 Global Methotrexate API Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Acute Lymphoblastic Leukemia
1.3.3 Non-Hodgkin's Lymphoma
1.3.4 Psoriasis
1.3.5 Rheumatoid Arthritis
1.3.6 Others
1.4 Global Market Growth Prospects
1.4.1 Global Methotrexate API Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Methotrexate API Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Methotrexate API Production Estimates and Forecasts (2019-2030)
1.4.4 Global Methotrexate API Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Methotrexate API Production Market Share by Manufacturers (2019-2024)
2.2 Global Methotrexate API Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Methotrexate API, Industry Ranking, 2022 VS 2023
2.4 Global Methotrexate API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Methotrexate API Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Methotrexate API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Methotrexate API, Product Offered and Application
2.8 Global Key Manufacturers of Methotrexate API, Date of Enter into This Industry
2.9 Methotrexate API Market Competitive Situation and Trends
2.9.1 Methotrexate API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Methotrexate API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Methotrexate API Production by Region
3.1 Global Methotrexate API Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Methotrexate API Production Value by Region (2019-2030)
3.2.1 Global Methotrexate API Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Methotrexate API by Region (2025-2030)
3.3 Global Methotrexate API Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Methotrexate API Production by Region (2019-2030)
3.4.1 Global Methotrexate API Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Methotrexate API by Region (2025-2030)
3.5 Global Methotrexate API Market Price Analysis by Region (2019-2024)
3.6 Global Methotrexate API Production and Value, Year-over-Year Growth
3.6.1 North America Methotrexate API Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Methotrexate API Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Methotrexate API Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Methotrexate API Production Value Estimates and Forecasts (2019-2030)
4 Methotrexate API Consumption by Region
4.1 Global Methotrexate API Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Methotrexate API Consumption by Region (2019-2030)
4.2.1 Global Methotrexate API Consumption by Region (2019-2030)
4.2.2 Global Methotrexate API Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Methotrexate API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Methotrexate API Consumption by Country (2019-2030)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Methotrexate API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Methotrexate API Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Methotrexate API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Methotrexate API Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Methotrexate API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Methotrexate API Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Purity
5.1 Global Methotrexate API Production by Purity (2019-2030)
5.1.1 Global Methotrexate API Production by Purity (2019-2024)
5.1.2 Global Methotrexate API Production by Purity (2025-2030)
5.1.3 Global Methotrexate API Production Market Share by Purity (2019-2030)
5.2 Global Methotrexate API Production Value by Purity (2019-2030)
5.2.1 Global Methotrexate API Production Value by Purity (2019-2024)
5.2.2 Global Methotrexate API Production Value by Purity (2025-2030)
5.2.3 Global Methotrexate API Production Value Market Share by Purity (2019-2030)
5.3 Global Methotrexate API Price by Purity (2019-2030)
6 Segment by Application
6.1 Global Methotrexate API Production by Application (2019-2030)
6.1.1 Global Methotrexate API Production by Application (2019-2024)
6.1.2 Global Methotrexate API Production by Application (2025-2030)
6.1.3 Global Methotrexate API Production Market Share by Application (2019-2030)
6.2 Global Methotrexate API Production Value by Application (2019-2030)
6.2.1 Global Methotrexate API Production Value by Application (2019-2024)
6.2.2 Global Methotrexate API Production Value by Application (2025-2030)
6.2.3 Global Methotrexate API Production Value Market Share by Application (2019-2030)
6.3 Global Methotrexate API Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Rochem International
7.1.1 Rochem International Methotrexate API Company Information
7.1.2 Rochem International Methotrexate API Product Portfolio
7.1.3 Rochem International Methotrexate API Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Rochem International Main Business and Markets Served
7.1.5 Rochem International Recent Developments/Updates
7.2 Fermion
7.2.1 Fermion Methotrexate API Company Information
7.2.2 Fermion Methotrexate API Product Portfolio
7.2.3 Fermion Methotrexate API Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Fermion Main Business and Markets Served
7.2.5 Fermion Recent Developments/Updates
7.3 Avra Laboratories
7.3.1 Avra Laboratories Methotrexate API Company Information
7.3.2 Avra Laboratories Methotrexate API Product Portfolio
7.3.3 Avra Laboratories Methotrexate API Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Avra Laboratories Main Business and Markets Served
7.3.5 Avra Laboratories Recent Developments/Updates
7.4 LGM Pharma
7.4.1 LGM Pharma Methotrexate API Company Information
7.4.2 LGM Pharma Methotrexate API Product Portfolio
7.4.3 LGM Pharma Methotrexate API Production, Value, Price and Gross Margin (2019-2024)
7.4.4 LGM Pharma Main Business and Markets Served
7.4.5 LGM Pharma Recent Developments/Updates
7.5 CF Pharma
7.5.1 CF Pharma Methotrexate API Company Information
7.5.2 CF Pharma Methotrexate API Product Portfolio
7.5.3 CF Pharma Methotrexate API Production, Value, Price and Gross Margin (2019-2024)
7.5.4 CF Pharma Main Business and Markets Served
7.5.5 CF Pharma Recent Developments/Updates
7.6 HRV Global
7.6.1 HRV Global Methotrexate API Company Information
7.6.2 HRV Global Methotrexate API Product Portfolio
7.6.3 HRV Global Methotrexate API Production, Value, Price and Gross Margin (2019-2024)
7.6.4 HRV Global Main Business and Markets Served
7.6.5 HRV Global Recent Developments/Updates
7.7 Elixir Pharmaceuticals
7.7.1 Elixir Pharmaceuticals Methotrexate API Company Information
7.7.2 Elixir Pharmaceuticals Methotrexate API Product Portfolio
7.7.3 Elixir Pharmaceuticals Methotrexate API Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Elixir Pharmaceuticals Main Business and Markets Served
7.7.5 Elixir Pharmaceuticals Recent Developments/Updates
7.8 Sigmak Lifesciences
7.8.1 Sigmak Lifesciences Methotrexate API Company Information
7.8.2 Sigmak Lifesciences Methotrexate API Product Portfolio
7.8.3 Sigmak Lifesciences Methotrexate API Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Sigmak Lifesciences Main Business and Markets Served
7.8.5 Sigmak Lifesciences Recent Developments/Updates
7.9 Aspen Biopharma
7.9.1 Aspen Biopharma Methotrexate API Company Information
7.9.2 Aspen Biopharma Methotrexate API Product Portfolio
7.9.3 Aspen Biopharma Methotrexate API Production, Value, Price and Gross Margin (2019-2024)
7.9.4 Aspen Biopharma Main Business and Markets Served
7.9.5 Aspen Biopharma Recent Developments/Updates
7.10 Mesochem Technology
7.10.1 Mesochem Technology Methotrexate API Company Information
7.10.2 Mesochem Technology Methotrexate API Product Portfolio
7.10.3 Mesochem Technology Methotrexate API Production, Value, Price and Gross Margin (2019-2024)
7.10.4 Mesochem Technology Main Business and Markets Served
7.10.5 Mesochem Technology Recent Developments/Updates
7.11 BioVectra
7.11.1 BioVectra Methotrexate API Company Information
7.11.2 BioVectra Methotrexate API Product Portfolio
7.11.3 BioVectra Methotrexate API Production, Value, Price and Gross Margin (2019-2024)
7.11.4 BioVectra Main Business and Markets Served
7.11.5 BioVectra Recent Developments/Updates
7.12 Bulat Pharmaceutical
7.12.1 Bulat Pharmaceutical Methotrexate API Company Information
7.12.2 Bulat Pharmaceutical Methotrexate API Product Portfolio
7.12.3 Bulat Pharmaceutical Methotrexate API Production, Value, Price and Gross Margin (2019-2024)
7.12.4 Bulat Pharmaceutical Main Business and Markets Served
7.12.5 Bulat Pharmaceutical Recent Developments/Updates
7.13 South Pharmaceutical
7.13.1 South Pharmaceutical Methotrexate API Company Information
7.13.2 South Pharmaceutical Methotrexate API Product Portfolio
7.13.3 South Pharmaceutical Methotrexate API Production, Value, Price and Gross Margin (2019-2024)
7.13.4 South Pharmaceutical Main Business and Markets Served
7.13.5 South Pharmaceutical Recent Developments/Updates
7.14 Think Chemical
7.14.1 Think Chemical Methotrexate API Company Information
7.14.2 Think Chemical Methotrexate API Product Portfolio
7.14.3 Think Chemical Methotrexate API Production, Value, Price and Gross Margin (2019-2024)
7.14.4 Think Chemical Main Business and Markets Served
7.14.5 Think Chemical Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Methotrexate API Industry Chain Analysis
8.2 Methotrexate API Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Methotrexate API Production Mode & Process
8.4 Methotrexate API Sales and Marketing
8.4.1 Methotrexate API Sales Channels
8.4.2 Methotrexate API Distributors
8.5 Methotrexate API Customers
9 Methotrexate API Market Dynamics
9.1 Methotrexate API Industry Trends
9.2 Methotrexate API Market Drivers
9.3 Methotrexate API Market Challenges
9.4 Methotrexate API Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer

Companies Mentioned:

Rochem International
Fermion
Avra Laboratories
LGM Pharma
CF Pharma
HRV Global
Elixir Pharmaceuticals
Sigmak Lifesciences
Aspen Biopharma
Mesochem Technology
BioVectra
Bulat Pharmaceutical
South Pharmaceutical
Think Chemical

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂